PopulationsHumans

Obesity Prevalence in the Patient Neighborhood and Outcomes of Antiobesity Medication Mediated by Treatment Continuation: Structured Equation Modeling Approach

ADA Scientific Sessions 2026 Abstract

The paper

Kibum Kim, Mohammad Alnuman, Ting Dai,

Johnson Y. Osei, Gregory S. Calip, Brian Layden, Daniel Touchette, Jacob Krive,

Chicago

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Poster 2007-P

doi.org/10.2337/db26-2007-p

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Diabetes, Obesity & Metabolism · 8 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026